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ABSTRACT
The most abundant aminoacid in the human body, 2-aminoethanesulphonic acid (H2NCH2CH2SO3H), is surprisingly stable and
reacts exceedingly slowly even with the most powerful oxidizing agents like acidic bromate. Oxidation occurs only on the
nitrogen centre to give the corresponding N-derivatives. No activity is observed at the sulphonic acid group and no cleavage of
the C–S bond is observed. The stoichiometry of the oxidation of 2-aminoethanesulphonic acid by bromate is complex, yielding a
mixture of monobromo- and dibromotaurines, oximes as well as the corresponding dimeric azo-compounds. In the presence of
added bromide, the stoichiometry of the reaction is:
2BrO3
– + 3H2NCH2CH2SO3H + 6H
+ + 4Br– → 3Br2NCH2CH2SO3H + 6H2O.
Monobromotaurine is formed as an intermediate product before formation of the dibromotaurine. Aqueous bromine reacts quan-
titatively with 2-aminomethanesulphonic acid according to the stoichiometry:
H2NCH2CH2SO3H + 2Br2 → Br2NCH2CH2SO3H + 2Br– + 2H+.
This reaction is strongly inhibited by acid due to the deactivation of the amino group to electrophilic attack by protonation. The
formation of N-bromotaurines is suggested as a possible mechanism by which taurine can moderate the oxidative toxicity of
bromine and hypobromous acid in the slightly basic physiological environments.
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1. Introduction
The reactions of small organic sulphur compounds with
oxyhalogens have presented to us a wide range of nonlinear
behaviour.2 In a recently established series we have exclusively
examined the kinetics and mechanisms of the oxidation of
sulphur compounds with oxyhalogens and halogens.3 Any
reasonable explanation of the origin of nonlinear behaviour
involving sulphur compounds has to include the kinetics and
mechanism of the main driving reactions. The reaction of
chlorite and thiourea,4 for example, had shown complex
patterning5 and symmetry-breaking bifurcations,6 clock reaction
characteristics,7 and even chemical chaos.8 We postulated a
mechanism which included a steady and progressive oxidation
of the sulphur centre in thiourea from the sulphenic acid to the
sulphinic acid, the sulphonic acid and finally to the sulphate
after cleavage of the C–S bond.7 Other kinetic studies which
involved the oxidation of formamidinesulphinic acid by chlorite
gave results that supported this postulated mechanism.9
The oxidations of sulphonic acids are difficult to deduce mech-
anistically especially if they have an amino group at the - or
-positions. The reaction of chlorite with aminomethane-
sulphonic acid is very slow and does not give quantitative
formation of sulphate, as expected from the cleavage of the C–S
bond under the influence of a strong oxidizing agent such as
chlorite.10 Sulphamic acid and methylsulphamic acid do not
give sulphate either upon oxidation as the sulphonic acid group
cannot and is not further oxidized. This behaviour seems preva-
lent in all aminoacids based on the sulphonic acid group.11
The most important -aminosulphonic acid in physiological
mechanisms is 2-aminoethanesulphonic acid, taurine.13 Taurine
has been implicated in several physiological roles, but there has
been no firm and conclusive mechanistic study of how it func-
tions. For example, what is the mechanism by which taurine and
isethionic acid inhibit calcium-activated respiration in liver
mitochondria?14 In vivo taurine studies that have been done so
far have only helped to establish that there is a special stabil-
ity associated with taurine, and that the amino group of the
molecule is the only one that can engage in reactions.10 The range
of taurine implication in several roles in the human body made
us want to take a closer look at its reactivity.
Taurine is a major constituent of the free aminoacid pool in
most animal tissues, and often occurs in concentrations higher
than those of all the other aminoacids.15 It is also highly concen-
trated in neurologically excitable tissues like the brain and in
membranes such as the retina.16 Taurine can be acquired through
dietary processes, but also, due to its stability, has been consid-
ered the biochemically inert end-product of methionine and
cysteine metabolism.17 Among the several roles of taurine is
osmoregulation, in which it regulates the osmotic pressure of the
cells.18 It also attaches to cells and stimulates processes like
glycolysis.19 In conjunction with eosinophils, taurine is known to
kill the schistosomula of Schistosoma mansoni and S. haematobium
in vitro.20
The most controversial role taurine is supposed to play in the
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human body, however, is as an antioxidant.21 It has been implied
that taurine, hypotaurine and their metabolic precursors act as
antioxidants in vivo.22 The mechanism of such a process is still
very sketchy, but must involve the scavenging of the standard
reactive oxygen species: superoxide radical,23 O2•
–, hydroxyl
radical,24 •OH, and peroxide,25 H2O2, and perhaps other damag-
ing oxyhalogen species such as HOBr and HOCl.
The link between taurine and possible physiological mecha-
nisms is difficult to assess. It is known, however, that myelo-
peroxidase (MPO) and eosinophil peroxidase (EPO) catalyse the
oxidation of bromide and chloride ions by H2O2 to produce
HOBr or HOCl,26 which rapidly react with amines to give long-
lived bromo- and chloramines.27 Could the bromamines formed
regulate the oxidative toxicity of the peroxides?
MPO and EPO have a role in killing microorganisms and inac-
tivation of viruses by leukocytes.28 Apart from Cl– and Br–, these
enzymes also catalyse the oxidation of SCN– by H2O2 to produce
the (pseudo)halogen, hypohalous acid, HOX or the hypohalite
anion, OX–. HOX/OX– are in rapid equilibrium and they possess
antimicrobial and antiviral activity.29 However, they also damage
host tissues, contribute to DNA damage, and cause inflamma-
tory tissue injury.30 Blood concentrations of chloride ions are
about 0.1 M, bromide ions 0.001 M, iodide 10–6 M, and thio-
cyanate between 0.02 and 0.12 mM.31 The abundance of chloride
suggests that it is the physiological substrate for MPO. However,
even though EPO has antimicrobial activity in the presence of
H2O2 and Cl
–, some studies have shown that EPO is less active
than MPO with Cl– as substrate.32 There is evidence to suggest
that Br– may be the physiological substrate for EPO:33
H2O2 + Br
– → HOBr + H2O (catalysed by EPO/H+). R1
Toxicity of HOBr can then be moderated by amines by produc-
ing milder oxidizing bromamines:
HOBr + RNH2 → RNHBr + H2O. R2
We had conjectured that the amine group of taurine might
play such a role as in reaction R2, above, in cytoprotectivity.
Bromide oxidation, however, has always been difficult to mea-
sure in physiological conditions. The formation, by the more
abundant chloride ions, of monochloramines can lead to the
direct formation of monobromamines:
RNHCl + Br– → RNHBr + Cl–. R3
Thus formation of bromamines does not indicate that HOBr
toxicity had been moderated by the amine.34 An experimental
study that isolated the bromide ion could shed light on the
possible cytoprotectivity of amines to possible tissue damage by
HOBr.
Recent studies have demonstrated that human neutrophils
stimulated with phorbol myristate acetate, PMA, or opsonized
zymosan particles destroyed cell targets by a myeloperoxidase-
dependent procedure that could be inhibited by compounds
known to scavenge HOCl.35 Attempts to measure the direct chlo-
ride peroxidation products by intact cells were quantitatively
performed by the use of taurine to form chlorotaurines. Our
own previous studies have also clearly shown the formation of
chloramines from the oxidation of taurine by chlorite under
neutral to slightly acidic pH conditions.10 The monochloramine
initially formed disproportionated in acidic conditions to give
back taurine and dichlorotaurine.
The present work focuses on the bromide ion and the possible
moderation of bromine and hypobromous acid toxicity by
taurine. In its oxidized form, we introduce bromine in the form
of Br(V), BrO3
– and Br(0), Br2(aq). These conditions are extremely
oxidizing, and taurine should be able to protect tissue from oxi-
dative damage from Br2 and HOBr by the formation of relatively
stable bromotaurines. There are two important factors that need
to be considered before such an assertion can be made, and we
intend to investigate both factors in this manuscript: (a) how
rapidly can taurine mop up the halogen and oxyhalogen at
physiological pH’s; and (b) can taurine be regenerated such that
it can continue moderating the toxicity of HOBr? The rate of
reaction of taurine with the oxidant should be faster than the rate
of damage of tissue by the oxidant for taurine to qualify as an
antioxidant.
The primary aim of the work reported here is to examine the
oxidation of taurine to form bromotaurines and to evaluate the
mechanism of the reaction. Mechanistic data on this reaction will
assist in evaluating some of the physiological roles of taurine.
2. Experimental
2.1. Materials
The following reagent grade chemicals were used without
further purification: sodium bromate, sodium perchlorate,
potassium iodide, perchloric acid (72%), sodium thiosulphate
(Fisher), bromine, taurine and D2O (Aldrich). Aqueous bromine
solutions were standardized by adding excess potassium iodide
and titrating the liberated iodine against standard thiosulphate
with freshly prepared starch as indicator.36 The concentration
was also determined by measuring the absorbance at 390 nm
where the extinction coefficient of bromine37 had been deduced
as 142 l mol–1 cm–1. Bromine solutions, being volatile, were kept
capped and were standardized before each set of experimental
runs.
2.2. Methods
The reactions of bromate and taurine were slow enough to be
followed on a Perkin Elmer Lambda 2S UV-visible spectro-
photometer. The absorbance of bromine at 390 nm was moni-
tored. The faster reactions of bromine and taurine were followed
on a Hi-Tech Scientific SF61AF stopped-flow spectrophotometer.
1H NMR spectra of taurine and the bromotaurines were ob-
tained on a JEOL GX 270 spectrometer using D2O as the solvent
and internal standard. All kinetic experiments were performed
at 25.0 ± 0.5°C and an ionic strength of 1.0 M (NaClO4). The
stoichiometric determinations were performed by varying the
amount of bromate while keeping the taurine concentration
constant. The required stoichiometry was determined as the
point just before the reaction solution produced bromine.
3. Results
3.1. Stoichiometry
The stoichiometry of the BrO3
––taurine reaction is very com-
plex in highly acidic media. The notable result was the lack of
sulphate in the product solution. Thus the C–S bond in taurine
could not be cleaved as had been observed in other small organic
sulphur molecules when subjected to a strong oxidizing agent.
The reaction gave a mixture of products: Br(H)NCH2CH2SO3H,
Br2NCH2CH2SO3H and HO(H)CH2CH2SO3H, all of which give
nearly identical 1H NMR spectra. Reproducible stoichiometry
could be obtained from solutions in which Br– was deliberately
added to the reaction mixture to produce a mixture of the
monobromo- and dibromotaurines:
2BrO3
– + 3H2NCH2CH2SO3H + 6H
+ + 4Br– →
3Br2NCH2CH2SO3H + 6H2O. R4
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Stoichiometry R5 is first obtained before R4:
BrO3
– + 3H2NCH2CH2SO3H + 3H
+ + 2Br– →
3Br(H)NCH2CH2SO3H + 3H2O R5
and in the absence of further bromide, the monobromotaurine
formed in stoichiometry R5 disproportionated in high acid envi-
ronments to give dibromotaurine and taurine:
2Br(H)NCH2CH2SO3H →
Br2NCH2CH2SO3H + H2NCH2CH2SO3H R6
The protonation of the amine group at high acid concentration
tends to pull the equilibrium of reaction R6 to the right. The
stoichiometry of the Br2–taurine reaction, however, was very
clean and gave a 1:2 stoichiometric ratio:
H2NCH2CH2SO3H + 2Br2 →
Br2NCH2CH2SO3H + 2Br
– + 2H+ R7
Monobromotaurine and dibromotaurine could easily be quan-
tified in the reaction product by their rapid reaction with excess
iodide to produce iodine which could then be spectrophotomet-
rically determined:
Br(H)NCH2CH2SO3H + 2I
– + H+ →
2H2NCH2CH2SO3H + I2(aq) + Br
– R8
Excess iodide was essential in reaction R8 to give the relatively
inert I3
– which discouraged any electrophilic iodination of the
amino group. The oxidizing equivalents with respect to
thiosulfate did not change after addition of excess iodide.
Monobromotaurine retained 2 mol of oxidizing equivalent, and
its concentration could also be determined by its ability to
oxidize 5-thio-2-nitrobenzoic acid to its dimer.38
3.2. Product Identification
The products were identified by the use of 1H NMR and UV
spectroscopy. Figure 1a shows a series of NMR spectra of pure
taurine (A), taurine in high acidic environments (pH 0.00, spec-
trum B) and the product solution of the bromate–taurine reac-
tion (C). In all three spectra the two characteristic triplets from
the CH2-CH2 backbone of taurine are evident. The slight down-
field shift of the two triplets is expected from the protonation of
the amino group in taurine (spectrum B). The free C–N bond
rotation (after protonation) also removes the slight splitting of
the triplet peaks observed in spectrum A. The product solution
spectrum shows a further slight shift downfield as expected
when the hydrogens on the amino group are replaced by
bromine. These NMR spectra show that the basic structure of
taurine is unaltered during this oxidation. No sulphate was
detected in the product solution, confirming that no reactivity
occurs on the sulphonic acid moiety. The UV spectrum of the
bromine–taurine reaction product is shown in Fig. 1b. The
dibromotaurine product was easily identified by its UV spec-
trum and its 1H NMR spectrum. The UV spectrum of dibromo-
taurine shows a strong absorption peak at 240 nm with an ab-
sorptivity of 2713 l mol–1 cm–1 and another peak at 336 nm with
ε = 371 l mol–1 cm–1. Monobromotaurine, on the other hand, has a
single, relatively weak absorption peak at 288 nm (ε = 430 l mol–1
cm–1). The product spectrum obtained in Fig. 1b is exactly the one
given in the literature for dibromotaurine. The spectrum was
taken from reaction solutions derived from stoichiometric
amounts of bromine and taurine to remove the expected bro-
mine peak at 390 nm. The dibromotaurine solution gave the
same NMR spectrum as the one in Fig. 1a (spectrum C).
Equimolar solutions of bromine and taurine gave monobromo-
taurine as the predominant product:
H2NCH2CH2SO3H + Br2 →
Br(H)NCH2CH2SO3H + Br
– + H+ R9
At high acid concentrations, however, the monobromotaurine
slowly decayed to be replaced by a mixture of taurine, mono-
bromo- and dibromotaurine as in reaction R6.
3.3. Reaction Dynamics
The bromate–taurine reaction was extremely slow and some-
times needed days (a week or two) for the reaction to proceed to
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Figure 1. a, 1H NMR spectral traces of pure taurine at pH 5 (spectrum A) and spectrum of the bromate–taurine reaction at pH 0 (spectrum B). The
basic CH2-CH2 backbone is maintained throughout. b, UV spectrum of the product solution of the bromine–taurine reaction showing the strong
peak at 240 nm which signifies dibromotaurine. [Br2]0 = 0.006 M, [Taurine]0 = 0.003 M
a
b
completion. This is an indication of how stable and unreactive
taurine is, even when subjected to an excess of a strong oxidizing
agent. In the UV and visible regions of the spectrum the reaction
mixture showed absorption at 240 nm, 324 nm and 390 nm. The
peak at 240 nm is by far the strongest. Figure 2 shows UV spectral
scans taken every 30 s. The solid lines represent the first 360 s,
where the peak at 324 nm increases, and the dotted lines repre-
sent the region in which the peak at 324 nm rapidly decreases
with a concomitant decrease in the peak at 390 nm. No discern-
ible peak is evident in the spectra at 390 nm during the first 360 s
of the reaction. The observed absorbance readings obtained at
390 nm are a summation of contributions from bromine,
monobromo- and dibromamines. Taurine itself shows no strong
absorption at this wavelength. The insert shows specific activi-
ties at the two particular wavelengths of 324 nm and 390 nm.
Absorption at 324 nm is attributed mainly to monobromotaurine
and that at 390 nm to Br2. Although literature claims that
monobromotaurine has an absorption peak at 288 nm, this peak
is not observed due to interference from other species also
absorbing at 288 nm, to the extent that there is no real correlation
between the peak at 288 nm and the concentration of mono-
bromotaurine. Applying the Beer-Lambert law for monobromo-
taurine at 288 nm gives an anomalously high reading. Initially
there is an accumulation of monobromotaurine as well as Br2.
The monobromotaurine concentration reaches a peak at the
same time that bromine concentrations attain a peak and then
decays. Although 324 nm does not represent an absorption peak
for monobromotaurine, it is displaced far enough away from the
regions where the dibromotaurine absorbs too strongly.
From an analysis of the combination of the slow reaction R4
and the very rapid reaction R7, the bromate–taurine reaction
appeared to be one of those typical clock reactions with variable
stoichiometry based on initial concentrations with an induction
period before formation of bromine. The observed reaction
dynamics, however, did not give a clear induction period in con-
ditions of [BrO3
–]0 >> [H2NCH2CH2SO3H]0. Figure 3 shows that
the reaction gives a slow bromine formation even at the initial
part of the reaction. This rate of bromine formation keeps in-
creasing in what appears to be an autocatalytic process. The ini-
tial rate of formation of bromine gave an [H+]0
2 dependence. The
effect of [BrO3
–]0 was nearly the same as that for acid except for
the dependence of the initial rate of formation of bromine which
was unit order with respect to [BrO3
–]0.
The effect of taurine on the reaction is shown in Fig.s 4a and 4b.
Figure 4a shows the UV spectra of products at t = ∞. For as long
as [BrO3
–]0 >> [H2NCH2CH2SO3H]0, the amount of bromine pro-
duced is proportional to [H2NCH2CH2SO3H]0. This is due to the
extension of stoichiometry R4. After full consumption of taurine
and monobromotaurine, any further bromide formed in reac-
tions R7 and R9 will be converted to bromine by the excess
bromate:
BrO3
– + 5Br– + 6H+ → 3Br2 + 3H2O R10
Figure 4b shows the rapid autocatalytic increase in bromine as
the initial taurine concentrations are increased.
The direct reaction of taurine and bromine was extremely fast,
especially in neutral and slightly basic environments. Figure 5
shows a series of experiments run at varying initial taurine
concentrations. All the experiments shown were run in excess
bromine, thus ensuring complete oxidation of the taurine to
dibromotaurine. The observed initial rapid increase in
absorbance is due to the formation of the tribromide species, Br3
–.
The production of Br– in the initial stages of reaction R3 triggers
the rapid equilibrium:39
Br2 + Br
– → Br3– Keq = 17 R11
Bromine has an absorptivity of 142 l mol–1 cm–1 at  = 390 nm
while the tribromide complex has an absorptivity of 1006 l mol–1
cm–1.39 The isosbestic point for the Br2/Br3
– species is at 442 nm.
The absorptivity for both species at this wavelength is too low to
be of any analytical use. Br2, being a stronger electrophile, reacts
much faster than Br3
–, hence the initial accumulation of Br3
–.
The effect of acid on the bromine–taurine reaction was both
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Figure 2 Spectral scans of the bromate–taurine reaction taken every 30 s.
The insert shows the specific activities at 390 nm and 324 nm. The
absorbance at 324 nm is of the monobromotaurine intermediate species,
which attains a maximum concentration before falling to accommodate
the formation of the product species dibromotaurine. Bromine concen-
trations ( = 390 nm), are depleted due to their reaction with
monobromotaurine to form dibromotaurine. [BrO3
–]0 = 0.100 M, [H
+]0 =
2.00 M, [Taurine]0 = 0.010 M. To avoid confusion, the dotted spectra were
taken after the peak in bromine concentrations had been reached. Solid
lines represent rising absorbance at 390 nm
Figure 3 Absorbance traces showing the effect of acid on the
bromate–taurine reaction. [Taurine]0 = 0.10 M, [BrO3
–]0 = 0.40 M, [H
+]0 =
(a) 1.0 M, (b) 1.2 M, (c) 1.5 M, (c) 1.8 M, (e) 2.0 M
dramatic and surprising. Figure 6 shows some absorbance traces
of experiments run at varying acid concentrations. There is a
strong inhibitory effect by acid on the reaction such that the reac-
tion virtually shuts down when the acid concentrations exceed
0.100 M. Within a small range of acid concentrations, 0.0 <
[H+] < 0.10, there is an inverse dependence of the initial rate on
acid concentration. At [H+]o > 0.10 M the acid retardation attains
a limiting effect. To appreciate the retarding effect of acid better,
one should remember that all runs shown in Fig. 6 give, finally,
the same value for bromine absorbance.
3.4. Mechanism
Owing to the inertness of taurine at the C–S bond, the postu-
lated mechanism is very simple and not complicated by possible
intermediate species formed from taurine. The only possible
taurine species are taurine itself, mono- and dibromotaurine.
The mechanism involves mostly oxyhalogen reactions, whose
kinetics and kinetic parameters are well known. With a taurine
pKb of 9.46,
40 and pH conditions lower than 1.00, taurine will be
nearly 100% protonated at these reaction conditions:
H2NCH2CH2SO3H + H
+ → [H3NCH2CH2SO3H]+ R12
All reactivity will be on the protonated nitrogen centre. For all
reference to taurine in this manuscript, we assume the
protonated form.
With Br– initially added to the reaction mixture, the initiation
reaction is a pure oxyhalogen reaction in which the reactive
intermediates, HOBr and HBrO2, are formed:
BrO3
– + Br– + 2H+ → HBrO2 + HOBr R13
Reaction R13 is well known in all bromate oxidations and is
responsible for the observed second order kinetics in [H+] for all
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Figure 4. a, Effect of taurine in conditions of excess bromate concentra-
tions. These spectral scans were taken after the reaction had been incu-
bated for 14 days. [BrO3
–]0 = 0.10 M, [H
+]0 = (a) 2.0 M, [Taurine]0 = (a)
0.02 M, (b) 0.01 M, (c) 0.008 M, (d) 0.005 M, (e) 0.0025 M, (f) 0.001 M. b , The
absorbance–time traces for the reaction solutions with t∞ shown in
Fig. 4a. The traces show a rapidly-increasing rate of production of
bromine, but no real discernible induction period
Figure 5 The direct reaction of bromine and taurine. The reaction is very
fast and at pH > 4 the reaction is essentially over in 0.5 s. [Taurine]0 =
0.005 M. [Br2]0 = (a) 0.01 M, (b) 0.009 M, (c) 0.008 M, (d) 0.007 M, (e)
0.006 M, (f) 0.005 M
Figure 6 Effect of acid on the direct bromine–taurine reaction shown in
Fig. 5. [Br2]0 = 0.012 M. [Taurine]0 = 0.005 M. [H
+]0 = (a) 0.012 M, (b)
0.023 M, (c) 0.058 M, (d) 0.12 M
a
b
bromate oxidations.41 Br– can be replaced by any 2-electron
reductant. Hypobromous acid formed in R13 rapidly oxidizes
taurine in a 2-electron transfer process:
H2NCH2CH2SO3H + HOBr →
H(OH)NCH2CH2SO3H + Br
– + H+ R14
followed by:
H(OH)NCH2CH2SO3H + Br
– + H+ →
BrHNCH2CH2SO3H + H2O R15
Reactions R14 and R15 can be represented by a composite reac-
tion R16:
H2NCH2CH2SO3H + HOBr →
BrHNCH2CH2SO3H + H2O R16
Br– produced in R14 can be used to produce more reactive
species:
HBrO2 + Br
– + H+ → 2HOBr R17
We thus expect an autocatalytic build-up of the reactive species
and hence the rate of reaction should also increase with time.
This can be observed in the rate of formation of bromine (see
Figs 3 and 4b).
In the absence of initial concentrations of bromide, the reactive
species are formed by the direct oxidation of taurine by bromate:
BrO3
– + H2NCH2CH2SO3H + H
+ →
HBrO2 + H(OH)NCH2CH2SO3H R18
followed by successive 2-electron reductions to give HOBr and
Br–:
HBrO2 + H2NCH2CH2SO3H →
HOBr +H(OH)NCH2CH2SO3H R19
The final stage in the reduction of the bromine centre is reac-
tion R14. The overall stoichiometry of this initiation reaction is:
BrO3
– + 3H2NCH2CH2SO3H →
Br– + 3H(OH)NCH2CH2SO3H R20
The bromide produced in reaction R20 can then activate reac-
tion R13 to form the reactive species. Reaction R18 is not the
rate-determining step as the reaction follows second order de-
pendence in [H+], which indicates that reaction R13 is ultimately
the rate-determining step in this reaction. Standard bromate
solutions contain at least 10–6 M of Br–, which exists as a contami-
nant.42 This is sufficient to initiate reaction R8. The production of
Br– is autocatalytic (from reaction R13), and so very little Br– is
needed to initiate the reaction.
There is only one reaction pathway for the formation of bro-
mine in the reaction:43
HOBr + Br– + H+ → Br2(aq) + H2O R21
The rate of bromine formation is thus dependent on the rate of
formation of HOBr and Br–. Br– can be consumed to form
bromine as in reaction R21, above, or can react with the oxime,
reaction R15, to give the bromotaurines. Reactions R15 and R21
occur simultaneously, hence the absence of a noticeable induc-
tion period for this reaction. Figure 2 insert shows that Br2
concentrations rapidly increase, but later start to fall at the same
time as the concentration of monobromotaurine starts to fall.
Figure 6 shows that in pH conditions less than 2, the direct reac-
tion between taurine and bromine is very slow. Hence bromine
formed from reaction R21 accumulates without any appreciable
consumption of bromine from reactions R7 and R9. The
protonation of the nitrogen centre strongly retards the electro-
philic attack by bromine. If one assumes that the protonated
taurine species is inert, then the rate of the bromine–taurine
reaction becomes:
–d[Br2]/dt = [H2NCH2CH2SO3H]T[Br2]/(1 + Keq[H
+]) (1)
where [H2NCH2CH2SO3H]T is the total taurine concentration
which combines the protonated and the unprotonated forms
([H2NCH2CH2SO3H] + [H3NCH2CH2SO3H+]). Keq is the equilib-
rium constant of reaction R12. In the limit of high acid concentra-
tions, we expect the experimentally-observed inverse acid
dependence kinetics from this reaction.
3.5. Formation and Consumption of Monobromotaurine
Figure 2 shows that monobromotaurine and bromine initially
increase in concentration, and towards the end of the reaction,
they both decrease. The accumulation of bromine is simply due
to the very slow bromine–taurine reaction in high acid condi-
tions. Another slow reaction occurs between Br2 and bromo-
taurine:
Br(H)NCH2CH2SO3H + Br2 →
Br2NCH2CH2SO3H + Br
– + H+ R22
Reaction R22, being slow in high acid environments, cannot
mop up all the bromine as it is formed, hence its continued accu-
mulation. Any Br– formed in reaction R22 will produce more
bromotaurine (reaction R15) and more bromine (reaction R21).
Bromotaurine will continue to increase until all the taurine has
been consumed and converted to bromotaurine. After the total
consumption of taurine, there will be no more reactions in solu-
tion which can produce bromotaurine. There are two possible
routes for the consumption of bromotaurine: reactions R6 and
R22. In the presence of excess oxidant, reaction R22 predomi-
nates, which means both Br2 and bromotaurine will be simulta-
neously consumed (Fig. 2). Reaction R6, should it be significant,
will produce taurine which will react with Br2 as in reaction R9.
This sequence will be kinetically indistinguishable from reaction
R21.
3.6. Computer Simulations
The reaction was modelled using the abbreviated mechanism
shown in Table 1 (with the reactions now re-numbered M1 to
M11). The kinetic parameters for the well-known oxyhalogen
reactions M1–M3 were available from the literature.44 The
forward rate constant for reaction M7 was evaluated from this
study (see Fig. 5). Out of the remaining seven reactions M5 and
M10 were fast and not rate-determining in this reaction
network. M10, however, was important in determining the
observed retardation by acid through the assumption that no
electrophilic attack occurred on the protonated nitrogen centre.
The forward and reverse constants of M10 are related by the pKb
of taurine. Strict adherence to this ratio, however, gave poor sim-
ulation fits to the data. This could be attributed to the presence of
the strongly acidic sulphonic acid group. For example, after
fixing the forward rate constant at 1.0 × 108 × l mol–1 s–1, the
reverse reaction rate will also be fixed by pKb at 2.9 × 10
3 s–1.
Using this value did not reproduce the rate of formation of bro-
mine. Reaction M11 was used for stoichiometric consistency
only: it was not rate-determining with respect to consumption of
taurine, even though it is one of the slowest reactions in the
scheme. The full reaction stoichiometry can be obtained from a
linear combination of the following reactions:
2M1 + 3M2 + 2M3 + 3M6 + 3M11.
The most important reactions in the simulations were M1 and
M4. When Br– was initially added to the reaction mixture, reac-
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tion M1 became the rate-determining step. Without added Br–,
the reaction became most sensitive to the kinetic parameters for
reaction M4. The sequence of reactions
M4 + M9 + M6
produced Br– such that M4 was only important in the initial
stages of the reaction, but after enough Br– had been formed,
reaction M1 became the rate-determining step. To facilitate the
simulations we assumed the acid concentrations were in such
large excess that they were constant. This allowed us to use what
appear to be termolecular steps in the reaction mechanism: reac-
tions M4 and M5. In both cases, the third reagent has a constant
concentration, which reverts the reactions to pseudo-second
order. Reaction M8 is a composite of two consecutive steps. The
reaction scheme was simulated using semi-implicit fourth order
Runge-Kutta techniques.45 The comparison between experimen-
tal results and our simulations is shown in Fig. 7. There was a
reasonable fit between our model and experiments. The simula-
tions were able to reproduce the acid effect which was most
important because, while high acid concentration catalysed the
oxyhalogen reactions, it inhibited the needed electrophilic
attack on the amino group of taurine. The simulations could not
reproduce the observed data for absorbance at 324 nm (Fig. 2).
This is because the absorbance at 324 nm is due to a resultant of
several species and not just monobromotaurine. The simula-
tions, however, do predict the cresting of the concentrations of
monobromotaurine before falling to make way for dibromo-
taurine.
4. Conclusion
The reaction of taurine with acidic bromate is exceedingly
slow, due to the opposing effects of acid. Production of the
electrophilic oxidizing species derived from bromate is greatly
enhanced by acid, while electrophilic attack on the nitrogen
centre of taurine is strongly retarded by acid. Although the reac-
tion of aqueous bromine with taurine is very fast, it is also
retarded by acid. In physiological pH conditions of 7.4, we
would expect taurine rapidly to mop up any Br2 and HOBr, thus
moderating any toxicities derived from these species. The ability
of taurine to protect tissue from damage from halogens and
oxyhalogens is enhanced by its very high concentration.
Though it may not be as efficient as other antioxidants, its high
concentration will more than make up for its relatively sluggish
reactivity. We are not certain of the ultimate fate of the
bromotaurines in physiological conditions, but some percentage
is expected to be regenerated through disproportionation.
Taurine is constantly being formed from cysteine and methio-
nine metabolism and so its concentration can be regarded as
constant in physiological environments.
Recent experimental data have shown that the major meta-
bolic precursor to taurine, hypotaurine, reacts rapidly and effi-
ciently with the hydroxyl radical, •OH, superoxide radical, O2
•–
and hydrogen peroxide, H2O2.
46 The abilities to scavenge these
reactive oxygen species (ROS) rapidly is a prerequisite for a
molecule to act as an antioxidant in vivo.47 The other metabolic
precursors of taurine; cysteic acid and cysteamine are also poor
scavengers of ROS together with taurine. The cytoprotective
role of taurine may be solely restricted to the deactivation of
HOBr because taurine appears inefficient in moderating HOCl
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Figure 7 Comparison between experimental and modelling results
(squares). The observed disagreement between the simulations and ex-
perimental data at the beginning of the reaction is expected since the ex-
perimental data will contain background absorbance which cannot be
simulated. [BrO3
–]0 = 0.08 M, [H
+]0 = 2.5 M, [Taurine]0 = 0.008 M.
Table 1 Mechanism used for the bromate-taurine simulations.
Reaction no. Reaction Rate constants
M1 BrO3
– + Br– + 2H+ → HBrO2 + HOBr 2.1; 1.0 × 104
M2 HOBr + Br– + H+ → Br2 + H2O 8.9 × 109; 1.10 × 102
M3 HBrO2 + Br
– + H+ → 2HOBr 2.5 × 106; 2.0 × 10–5
M4 BrO3
– + RNH2 + H
+ → RNHOH + HBrO2 82
M5 RNHOH + Br– + H+ → RNHBr + H2O 5.5 × 103
M6 HOBr + RNH2 → RNHOH + Br– + H+ 1.0 × 105
M7 Br2 + RNH2 → RNHBr + Br– + H+ 3.8 × 105
M8 2RNHBr + H+ → RNBr2 + RNH3+ 4.2 × 106; 1.0 × 10–1
M9 HBrO2 + RNH2 → RNHOH + HOBr 1.5 × 103
M10 RNH2 + H
+ → RNH3+ 1.0 × 108; 4.2 × 105
M11 RNHBr + Br2 → RNBr2 + H+ + Br– 45
The units for the rate constants are deduced from the molecularity of the reaction except where the
solvent, water, is involved. Note that all acid concentrations were not varied, and thus reactions M4
and M5 are effectively bimolecular, and reaction M10 is first order.
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